title: Ischemia and necrotizing enterocolitis: where, when, and how.
abstract: While it is accepted that ischemia contributes to the pathogenesis of necrotizing enterocolitis (NEC), three important questions regarding this role subsist. First, where within the intestinal circulation does the vascular pathophysiology occur? It is most likely that this event begins within the intramural microcirculation, particularly the small arteries that pierce the gut wall and the submucosal arteriolar plexus insofar as these represent the principal sites of resistance regulation in the gut. Mucosal damage might also disrupt the integrity or function of downstream villous arterioles leading to damage thereto; thereafter, noxious stimuli might ascend into the submucosal vessels via downstream venules and lymphatics. Second, when during the course of pathogenesis does ischemia occur? Ischemia is unlikely to the sole initiating factor of NEC; instead, it is more likely that ischemia is triggered by other events, such as inflammation at the mucosal surface. In this context, it is likely that ischemia plays a secondary, albeit critical role in disease extension. Third, how does the ischemia occur? Regulation of vascular resistance within newborn intestine is principally determined by a balance between the endothelial production of the vasoconstrictor peptide endothelin-1 (ET-1) and endothelial production of the vasodilator free radical nitric oxide (NO). Under normal conditions, the balance heavily favors NO-induced vasodilation, leading to a low resting resistance and high rate of flow. However, factors that disrupt endothelial cell function, eg, ischemia-reperfusion, sustained low-flow perfusion, or proinflammatory mediators, alter the ET-1:NO balance in favor of constriction. The unique ET-1-NO interaction thereafter might facilitate rapid extension of this constriction, generating a viscous cascade wherein ischemia rapidly extends into larger portions of the intestine.
authors.affiliation: Center for Cell and Vascular Biology, Columbus Children's Research Institute, Columbus, OH 43205, USA. NowickiP@pediatrics.ohio-state.edu
authors.forename: Philip T
authors.initials: PT
authors.lastname: Nowicki
mesh_terms: D019332:Endothelin-1 / Q000378:metabolism; D020345:Enterocolitis, Necrotizing / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D007231:Infant, Newborn; D007413:Intestinal Mucosa / Q000098:blood supply*; D007511:Ischemia / Q000150:complications / Q000378:metabolism / Q000503:physiopathology*; D008833:Microcirculation / Q000503:physiopathology; D009569:Nitric Oxide / Q000378:metabolism; D013152:Splanchnic Circulation / Q000502:physiology
chemical_list: D019332:Endothelin-1; D009569:Nitric Oxide